triiodothyronine has been researched along with Anti-PIT-1 Antibody Syndrome in 2 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ansorge, C | 1 |
Seufert, J | 1 |
Meiss, F | 1 |
von Bubnoff, D | 1 |
De Bellis, A | 1 |
Bellastella, G | 1 |
Maiorino, MI | 1 |
Aitella, E | 1 |
Lucci, E | 1 |
Cozzolino, D | 1 |
Bellastella, A | 1 |
Bizzarro, A | 1 |
Giugliano, D | 1 |
Esposito, K | 1 |
2 other studies available for triiodothyronine and Anti-PIT-1 Antibody Syndrome
Article | Year |
---|---|
Sequential occurrence of primary and secondary hypothyroidism during treatment with nivolumab: pitfalls in immuno-oncological therapy and endocrinological diagnostic procedures.
Topics: Adult; Antineoplastic Agents, Immunological; Autoimmune Hypophysitis; Humans; Hydrocortisone; Hypopi | 2018 |
Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age.
Topics: Adolescent; Adrenocorticotropic Hormone; Autoantibodies; Autoimmune Hypophysitis; Child; Dwarfism, P | 2016 |